ID19548A - Virus mva rekombinan yang mengekspresikan antigen-antigen virus demam dan penggunaan daripadanya dalam vaksin-vaksin - Google Patents

Virus mva rekombinan yang mengekspresikan antigen-antigen virus demam dan penggunaan daripadanya dalam vaksin-vaksin

Info

Publication number
ID19548A
ID19548A IDP973270A ID973270A ID19548A ID 19548 A ID19548 A ID 19548A ID P973270 A IDP973270 A ID P973270A ID 973270 A ID973270 A ID 973270A ID 19548 A ID19548 A ID 19548A
Authority
ID
Indonesia
Prior art keywords
thems
recombined
vaccines
fever
antigens
Prior art date
Application number
IDP973270A
Other languages
English (en)
Inventor
Mary Jane Cardosa
Gerd Sutter
Volker Erfle
Original Assignee
Bavarian Nordic Res Inst As
Univ Malaysia Serawak
Gsf Forschungszentrum Umwelt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bavarian Nordic Res Inst As, Univ Malaysia Serawak, Gsf Forschungszentrum Umwelt filed Critical Bavarian Nordic Res Inst As
Publication of ID19548A publication Critical patent/ID19548A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
IDP973270A 1996-09-24 1997-09-23 Virus mva rekombinan yang mengekspresikan antigen-antigen virus demam dan penggunaan daripadanya dalam vaksin-vaksin ID19548A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK103596 1996-09-24

Publications (1)

Publication Number Publication Date
ID19548A true ID19548A (id) 1998-07-23

Family

ID=8100273

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP973270A ID19548A (id) 1996-09-24 1997-09-23 Virus mva rekombinan yang mengekspresikan antigen-antigen virus demam dan penggunaan daripadanya dalam vaksin-vaksin

Country Status (6)

Country Link
US (1) US6869793B2 (id)
EP (1) EP0951555A2 (id)
AU (1) AU4556597A (id)
ID (1) ID19548A (id)
MY (1) MY150893A (id)
WO (1) WO1998013500A2 (id)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1021545A2 (en) * 1997-09-23 2000-07-26 Bavarian Nordic Research Institute A/S Dengue virus antigens and treatment of dengue fever
US6582693B2 (en) 1998-11-30 2003-06-24 Lemery, S.A. De C.V. Recombinant MVA virus expressing the E2 gene of Bovine papillomavirus and its use in the therapy of tumors generated by papillomaviruses
US20040265324A1 (en) * 1999-03-23 2004-12-30 Cardosa Mary Jane Recombinant MVA virus expressing dengue virus antigens, and the use thereof in vaccines
US6682742B1 (en) 1999-05-28 2004-01-27 Gsf Forschungszentrum Fur Unwelt Und Gesundheit Gmbh Vector for integration of heterologous sequences into poxviral genomes
IL154712A0 (en) 2000-11-23 2003-10-31 Bavarian Nordic As Modified vaccinia ankara virus variant
US7628980B2 (en) 2000-11-23 2009-12-08 Bavarian Nordic A/S Modified vaccinia virus ankara for the vaccination of neonates
EP2345665A3 (en) * 2001-12-04 2012-02-15 Bavarian Nordic A/S Flavivirus NS1 subunit vaccine
DK1418942T3 (da) * 2001-12-10 2005-11-28 Bavarian Nordic As Poxvirus-holdige sammensætninger og fremgangsmåde til fremstilling deraf
HU227507B1 (hu) * 2001-12-20 2011-07-28 Bavarian Nordic As Eljárás poxvírusok kinyerésére és tisztítására fertõzött sejtekbõl
EP1420822B2 (en) * 2002-04-19 2017-07-05 Bavarian Nordic A/S Modified vaccinia virus ankara for the vaccination of neonates
PL372091A1 (en) * 2002-05-16 2005-07-11 Bavarian Nordic A/S Expression of genes in modified vaccinia virus ankara by using the cowpox ati promoter
NZ536502A (en) * 2002-05-16 2005-10-28 Bavarian Nordic As Recombinant poxvirus expressing homologous genes inserted into the poxviral genome for inducing an immune response in a mammal
WO2004015118A1 (en) 2002-08-07 2004-02-19 Bavarian Nordic A/S Vaccinia virus host range genes to increase the titer of avipoxviruses
PL215169B1 (pl) 2002-09-05 2013-10-31 Bavarian Nordic As Sposób amplifikacji wirusów, kompozycja zawierajaca pokswirusa uzyskanego tym sposobem oraz jego zastosowanie do otrzymywania szczepionki
ATE365220T1 (de) * 2002-11-25 2007-07-15 Bavarian Nordic As Mindestens zwei ati promotoren enthaltendes rekombinantes pockenvirus
CA2432738A1 (en) * 2003-02-26 2004-08-26 Philippe Despres New dengue and west nile viruses proteins and genes coding the foregoing, and their use in vaccinal, therapeutic and diagnostic applications
EP1784487B1 (en) * 2004-07-27 2011-08-24 THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES Identification of cross-reactive epitopes of flavivirus envelope glycoprotein
SG10201912554TA (en) 2005-03-23 2020-02-27 Genmab As Antibodies against cd38 for treatment of multiple myeloma
US20090269365A1 (en) * 2005-04-20 2009-10-29 University Of Washington Immunogenic vaccinia peptides and methods of using same
CU23586A1 (es) 2005-11-22 2010-10-30 Ct Ingenieria Genetica Biotech Métodos y proteínas para el tratamiento profiláctico y/o terapéutico de los cuatro serotipos del virus de dengue y otros flavivirus
US7913477B2 (en) * 2006-01-27 2011-03-29 William Anthony Harper Insert registration in packets
US20090230524A1 (en) * 2008-03-14 2009-09-17 Pao-Huei Chang Chien Semiconductor chip package having ground and power regions and manufacturing methods thereof
MX2011005886A (es) * 2008-12-05 2011-07-28 Inviragen Inc Composiciones, métodos y usos para inducir el crecimiento viral.
FR3042121A1 (fr) 2015-10-08 2017-04-14 Jean-Marc Limacher Composition anti-tumorale

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1341245C (en) * 1988-01-12 2001-06-05 F. Hoffmann-La Roche Ag Recombinant vaccinia virus mva
IL91304A0 (en) 1988-08-20 1990-03-19 Us Health Recombinant vaccinia virus for prevention of disease caused by flavivirus
MY109299A (en) * 1990-08-15 1996-12-31 Virogenetics Corp Recombinant pox virus encoding flaviviral structural proteins
US5514375A (en) * 1990-08-15 1996-05-07 Virogenetics Corporation Flavivirus recombinant poxvirus vaccine
US5494671A (en) * 1990-08-27 1996-02-27 The United States Of America As Represented By The Department Of Health And Human Services C-terminally truncated dengue and Japanese encephalitis virus envelope proteins
EP0575491B1 (en) * 1991-03-07 2003-08-13 Virogenetics Corporation Genetically engineered vaccine strain
GB9105383D0 (en) * 1991-03-14 1991-05-01 Immunology Ltd An immunotherapeutic for cervical cancer
US5369025A (en) * 1991-06-28 1994-11-29 The United States Of America As Represented By The Secretary Of Agriculture Recombinant fowlpox vaccine for protection against Marek's disease
UA68327C2 (en) * 1995-07-04 2004-08-16 Gsf Forschungszentrum Fur Unwe A recombinant mva virus, an isolated eukaryotic cell, infected with recombinant mva virus, a method for production in vitro of polypeptides with use of said cell, a method for production in vitro of virus parts (variants), vaccine containing the recombinant mva virus, a method for immunization of animals
US6074865A (en) * 1995-07-20 2000-06-13 The United States Of America As Represented By The Secretary Of The Army Recombinant dengue virus DNA fragment

Also Published As

Publication number Publication date
AU4556597A (en) 1998-04-17
MY150893A (en) 2014-03-14
US20030082205A1 (en) 2003-05-01
US6869793B2 (en) 2005-03-22
EP0951555A2 (en) 1999-10-27
WO1998013500A3 (en) 1998-06-18
WO1998013500A2 (en) 1998-04-02

Similar Documents

Publication Publication Date Title
ID19548A (id) Virus mva rekombinan yang mengekspresikan antigen-antigen virus demam dan penggunaan daripadanya dalam vaksin-vaksin
FI945483A (fi) Hepatiitti B - pinta-antigeenejä ja muita antigeenejä sisältäviä yhdistelmärokotteita
NO20004104D0 (no) Preparater omfattende virus og fremgangsmÕter for konsentrering av viruspreparater
ID26104A (id) Metoda-metoda dan bahan-bahan untuk mengobati dan mencegah radang jaringan mukosa
ID27458A (id) Komposisi-komposisi efervesen dan butiran efervesen kering
IL112860A0 (en) Recombinant viruses their preparation and their therapeutic uses
HK1083454A1 (en) Recombinant vaccine viruses expressing il-15 and methods of using the same 15(il-15)
DE69715482D1 (de) Herstellung von 1,1,1,3,3-Pentachlorbutan und von 1,1,1,3,3-Pentafluorbutan
DE69832184D1 (de) O-substituierte hydroxycumaranonderivate mit antitumoraler und antimetastatischer wirkung
ID23258A (id) Penarik pemberian-menyilang dan metodenya
IS5777A (is) Bóluefnisvakið lifrarbólgu B veiruafbrigði og notkun þess
ID20514A (id) Bejana metalurgi yang ditingkatkan dan metode penggunaan bejana tersebut
ID29864A (id) Penggunaan senyawa turunan 17-ketosteroid dan turunan, metabolit dan prekursornya dalam pengobatan virus hepatitis c dan togavirus lain
DE59709341D1 (de) Leuchtstoffzubereitung mit fein- und grossteiligen SiO2-Partikeln
BR9708979A (pt) Complexo imunogénico utilização do mesmo vacina processo para a preparação de um complexo imunogenico e utilização de uma proteína
EE9600180A (et) Anti-HIV kompositsioon, meetod selle valmistamiseks ja selle kasutamine
ID24941A (id) Antigen virus dengue dan pengobatan demam dengue
DE9401733U1 (de) Schließ- und Sicherungseinrichtung
DE9401732U1 (de) Schließ- und Sicherungseinrichtung
ID23693A (id) Formulasi bambuterol, pembuatan dan penggunaanya
ID16876A (id) Kombinasi sol dalam dan luar
ID28142A (id) Jenis virus penyebab hepatitis b vaksin dan penggunaannya
ZA944725B (en) Recombinant antigens from mumps virus and their use in vaccines
PT841943E (pt) Virus herpeticos avirulentos uteis como agentes tumoricidas e vacinas
KR950025969U (ko) 110v와 220v 겸용 플러그